[2021] Clinical Mass Spectrometry Market to Experience Better Growth with US $ 697.2 Million, Growing at a CAGR of 5.5% by 2027


The global clinical mass spectrometry market has witnessed continuous growth over the past few years and is expected to further grow during the forecast period (2021-2027). The research presents a comprehensive assessment of the market and contains future trends, current growth factors, attentive opinions, facts, historical data, and market data validated by the industry and statistically supported.

The Clinical Mass Spectrometry Market report presents the detailed analysis of the parent market on the basis of elite players, present, past, and futuristic data that will serve as a profitable guide for all competitors in the industry. Major players in the Clinical Mass Spectrometry market have been identified through secondary research, and their market shares have been determined through primary as well as secondary research. All actions, divisions, and measurement distributions were resolved using secondary sources and verified primary sources. The Clinical Mass Spectrometry Market report begins with a basic overview of industry life cycle, definitions, classifications, applications, and industry chain structure. All of these will help the major players to understand the scope of the market, its characteristics and how it will meet customer expectations. conditions.

Request a sample research report

The increasing investments in R&D activities by pharmaceutical companies are expected to drive the growth of the global clinical mass spectrometry market during the forecast period. In addition, mass spectrometry plays a major role in laboratory medicine. For example, in 2019, Biotage AB entered into a collaboration with Shandong Yingsheng Biotechnology Co., Ltd. to focus on the research, production and sale of in vitro diagnostic reagents and medical equipment. This collaboration aims to build a genetic detection platform and a detection platform by mass spectrometry around metabolomics and genetics.

Additionally, as part of this collaboration, Biotage and Yingsheng have agreed to develop clinical mass spectrometry applications in China, where Biotage will offer systems and consumables from its analytical chemistry portfolio and Yingsheng will sell it under its brand. Furthermore, the adoption of clinical mass spectrometry in laboratory-developed tests (LDT) is expected to drive the growth of this market during the forecast period. Technological advancements such as sensitive analytical capabilities and improvements continue to bring technology to the forefront of new scientific discovery and research applications. In addition, matrix-assisted laser desorption / ionization – time-of-flight (MALDI-TOF) has various applications in microbiology laboratories. MALDI-TOF systems are designated as medical devices that support FDA approved or CE marked testing. Additionally, tests that have received FDA clearance or CE mark in the recent past use MALDI-TOF for microbiological identifications, which is expected to drive market growth during the forecast period. These tests are different from the majority of the clinical mass spectrometry market, which is covered by laboratory developed tests (LDT).

Browse 43 market data tables and 33 figures spread over 169 pages and an in-depth table of contents on ‘Global Clinical Mass Spectrometry Market, By Product Type (Gas Chromatography-Mass Spectrometry Instrument (GC- MS), liquid chromatography-mass spectrometry (LC-MS)) Instrument, MALDI-TOF mass spectrometer, capillary electrophoresis-mass spectrometry and ion mobility spectrometry-mass spectrometry), by application (clinical tests, proteomics and discovery of drugs), by end user (research laboratories, diagnostic laboratories and hospitals), and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) Global forecasts to 2027 “

Key Points of the Clinical Mass Spectrometry Market:

  • Global Clinical Mass Spectrometry Market is expected to exhibit a CAGR of 5.5% during the forecast period (2019-2027), owing to the technological advancements in mass spectrometry and increasing adoption of spectrometry mass in tests developed in the laboratory.

  • Among the regions, Asia-Pacific is expected to experience significant growth in the global clinical mass spectrometry market during the forecast period owing to the high R&D investments of pharmaceutical companies in the region.

  • Among product types, Gas Chromatography-Mass Spectrometry (GC-MS) Instrument segment has occupied a dominant position in the clinical mass spectrometry market during the forecast period, due to the number growing adoption of this technology by players operating in the market

Buy this report with a flat rate US $ 2000 discount – https://www.coherentmarketinsights.com/promo/buynow/193

Reasons to buy this report

• Current and future prospects of the global clinical mass spectrometry market in developed and emerging markets
• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.
• Regions / countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies used by the main market players

Clinical Mass Spectrometry Market – Competitive Landscape

The major players operating in the global prosthetic sleeves market are as follows: Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies and Danaher Corporations

Contents

Chapter 1 Industry overview
1.1 Definition
1.2 Assumptions
1.3 Scope of the research
1.4 Market Analysis by Regions
1.5 Global Clinical Mass Spectrometry Market Size Analysis from 2021 to 2027
11.6 COVID-19 outbreak: impact on the clinical mass spectrometry industry

Chapter 2 Global Clinical Mass Spectrometry Competition by Types, Applications and Major Regions and Countries
2.1 Global Clinical Mass Spectrometry (Volume & Value) by Type
2.3 Global Clinical Mass Spectrometry (Volume & Value) by Regions

chapter 3 Production market analysis
3.1 Global Production Market Analysis
3.2 Regional production market analysis

Chapter 4 Global Sales, Consumption, Export, Import of Clinical Mass Spectrometry by Regions (2016-2021)
Chapter 5 North America Clinical Mass Spectrometry Market Analysis
Chapter 6 East Asia Clinical Mass Spectrometry Market Analysis
Chapter 7 Analysis of the clinical mass spectrometry market in Europe
Chapter 8 South Asia Clinical Mass Spectrometry Market Analysis
Chapter 9 Southeast Asia Clinical Mass Spectrometry Market Analysis
Chapter 10 Middle East Clinical Mass Spectrometry Market Analysis
Chapter 11 Africa Clinical Mass Spectrometry Market Analysis
Chapter 12 Analysis of the clinical mass spectrometry market in Oceania
Chapter 13 South America Clinical Mass Spectrometry Market Analysis
Chapter 14 Company Profiles and Key Figures of the Clinical Mass Spectrometry Industry
Chapter 15 Global Clinical Mass Spectrometry Market Forecast (2021-2027)
Chapter 16 Conclusion
Research methodology

Request the PDF brochure here @ https://www.coherentmarketinsights.com/insight/request-pdf/193

About Us

Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients from all walks of life, from Fortune 500 companies to nonprofits and startups looking to gain a foothold in the market. We excel in delivering unmatched actionable business insights across a variety of industry verticals, including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.

Contact us

Mr. Shah

Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837

About Hector Hedgepeth

Check Also

Oxford BioDynamics Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) Now Available in the UK

Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for …

Leave a Reply

Your email address will not be published.